Bonnie Burnham, DO
Family Medicine · Danville, VANPI 1093036493
Payments from drug & device makers
Across 80 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$258
- Amgen$244
- Novo Nordisk$196
- AbbVie$75
- Boehringer Ingelheim$73
- Pfizer$71
- plus $383 from 12 others
What the payments were for
- Food & beverage$1,300100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 16 | $258 |
| Amgen | 17 | $244 |
| Novo Nordisk | 11 | $196 |
| AbbVie | 5 | $75 |
| Boehringer Ingelheim | 4 | $73 |
| Pfizer | 4 | $71 |
| AstraZeneca | 4 | $66 |
| Bayer | 3 | $63 |
| Exact Sciences | 4 | $56 |
| Astellas Pharma US Inc | 3 | $52 |
| Merck | 2 | $27 |
| Tandem Diabetes Care, Inc. | 1 | $24 |
| Harmony Biosciences LLC | 1 | $18 |
| Intra-sana Laboratories | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $16 |
| GSK | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
| Cequr Corporation | 1 | $13 |
How this compares
$1,300 in reported general payments places this provider in the 70th percentile of 2,553 family medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 100 | $129,143 |
| MounjaroTirzepatide | 79 | $99,239 |
| EliquisApixaban | 43 | $58,215 |
| JanuviaSitagliptin Phosphate | 33 | $39,277 |
| FarxigaDapagliflozin Propanediol | 33 | $34,979 |
| WegovySemaglutide | 19 | $28,530 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $26,716 |
| JardianceEmpagliflozin | 15 | $22,352 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $20,055 |
| ProliaDenosumab | 11 | $19,494 |
| XareltoRivaroxaban | 13 | $16,108 |
| Repatha SureclickEvolocumab | 16 | $12,959 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $6,779 |
| Nebivolol Hcl | 35 | $4,278 |
| Rosuvastatin Calcium | 324 | $4,225 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy | $196 | $157,673119 claims |
| Lilly USA, LLCMounjaro | $258 | $99,23979 claims |
| PfizerEliquis | $71 | $58,21543 claims |
| MerckJanuvia | $27 | $39,27733 claims |
| AstraZenecaFarxiga | $66 | $34,97933 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $16 | $33,49547 claims |
| Boehringer IngelheimJardiance | $73 | $22,35215 claims |
| AmgenProlia | $244 | $19,49411 claims |
| Johnson & JohnsonXarelto | $14 | $16,10813 claims |
| AbbVieSynthroid | $75 | $3,27331 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Danville
- Stephan JannachDanville$3M
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Linda SchneiderHampton$2.1M
- Jennifer BrownMidlothian$1.3M
- Brian McCormickHampton$793K
- Jerome DanielNorth Chesterfield$779K
- Samir AbdelshaheedChesapeake$642K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.